ID   PPMI.I.1085.2
AC   CVCL_D5SS
SY   PPMI50086; PPMI_50086; CDIi054-A; FCDI_11348
DR   BioSamples; SAMEA115473842
DR   hPSCreg; CDIi054-A
DR   Wikidata; Q127383437
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50086 and PPMI_50086 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SR ! PPMI.I.1085.1
OI   CVCL_D5SU ! PPMI.I.1085.3
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
CH   CVCL_D5ST ! PPMI.I.1085.2.ISO.1
//